Username Password
S&P 500: 1,317.82 Change: +0.03%

IMMUNOGEN INC (IMGN)

Overview
Price 14.33
Price Change Today -$0.32 (-2.18%)
P&P rating Rating: 2
Zacks Rank 3 - HOLD
Open Price $14.63
Previous Close $14.65
Daily Range $14.25 - $14.63
52-Week Range $9.17 - $16.20
Volume 297,672
chart
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
Other Resources for IMGN
zacks.com
Commentary
Zacks Blog: Roche's Cancer Drug Moves Forward
March 30, 2012
Zacks Blog: Roche Reports Positive Data
September 30, 2011
Zacks Blog: Company News for July 7, 2011
July 7, 2011
ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
 
Brokerage Analyst Recommendations
8 Brokerage Firms Covering IMGN
 
    
Strong Buy
4
Buy
1
Hold
2
Sell
0
Strong Sell
1
Average Broker Recommendation (ABR): 2.13
 
IMGN Ratings:BUY  SELL  HOLD
IMGN Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

10 Buy
2 Sell
 
Free Options Trader Guide
Top Buy Analysis
BUY: IMGN Rating: 2
Company: IMMUNOGEN INC.
Points: 40.19
Start Price: $9.18
Start Date: 05/17/2010 9:22 PM
mdmoney
mdmoney
P&P Score: 98.46
Recs:
Targeted Antibody Payload (TAP), technology consists of a monoclonal antibody that binds specifically to an antigen target found on cancer cells with multiple copies of one of its cell-killing agents attached using one of its linkers.

Comments: 0 | Comment


Top Sell Analysis
SELL: IMGN Rating: 2
Company: IMMUNOGEN INC.
Points: -17.70
Start Price: $8.72
Start Date: 07/04/2009 12:02 AM
NegativeOne
NegativeOne
P&P Score: 10.83
Recs:

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 09/17/09 Zantrio.com Stock Picks for September 17, 2009 0
Zacks_Analysts
0.00 03/30/12 Roche's Cancer Drug Moves Forward - Analyst Blog 0
Zacks_Analysts
0.00 09/30/11 Roche Reports Positive Data - Analyst Blog 0
Zacks_Analysts
0.00 04/07/11 Encouraging Data on Roche's Drug - Analyst Blog 0
Zacks_Analysts
0.00 09/23/10 IMGN Cancer Drug Moves Ahead - Analyst Blog 0
Zacks_Analysts
0.00 08/30/10 Roche Cancer Drug Hits Roadblock - Analyst Blog 0
Zacks_Analysts
0.00 08/24/10 ImmonoGen Drug Gets Orphan Status - Analyst Blog 0
Zacks_Analysts
0.00 09/17/09 Amgen Taps ImmunoGen - Analyst Blog 0
Commentary
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $9.18
Points: +40.19
Created: 05/17/2010
Targeted Antibody Payload (TAP), technology consists of a monoclonal antibody that binds specifically to an antigen target found on cancer cells with multiple copies of one of its cell-killing agents attached using one of its linkers.

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $9.88
Points: +10.47
Created: 07/24/2009
$18.00 target

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $11.95
Points: +18.20
Created: 06/21/2011

Comments: 0 | Comment

Recs:
 
SELL: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $8.72
Points: -17.70
Created: 07/04/2009

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $7.58
Points: +32.63
Created: 04/03/2009
^_^

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $5.30
Points: +180.61
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
SELL: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $5.01
Points: -196.26
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $3.74
Points: +293.38
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $4.65
Points: +218.40
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: IMMUNOGEN INC. (IMGN) Rating: 2
Start Price: $4.22
Points: +249.80
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
dmonnie 0.22 BUY One to Three Months 06/21/2011 $11.95 $14.33
(+0.07%)
+19.92% +1.72% +18.20
mdmoney 98.46 BUY Three to Six Months 05/17/2010 $9.18 $14.33
(+0.07%)
+56.10% +15.91% +40.19 view
3mutts BUY One to Three Months 07/24/2009 $9.88 $14.33
(+0.07%)
+45.04% +34.57% +10.47 view
NegativeOne 10.83 SELL Week to a Month 07/04/2009 $8.72 $14.33
(+0.07%)
+64.33% +46.63% -17.70
f1ndforty 77.53 BUY Six Months to a Year 04/03/2009 $7.58 $14.33
(+0.07%)
+89.05% +56.42% +32.63 view
Maverick 98.16 BUY Six Months to a Year 01/01/2008 $5.30 $14.33
(+0.07%)
+170.38% -10.23% +180.61
edwill 31.54 SELL Six Months to a Year 01/01/2008 $5.01 $14.33
(+0.07%)
+186.03% -10.23% -196.26
Elroy 79.35 BUY Six Months to a Year 01/01/2008 $3.74 $14.33
(+0.07%)
+283.16% -10.23% +293.38
Kien 79.35 BUY Six Months to a Year 01/01/2008 $4.65 $14.33
(+0.07%)
+208.17% -10.23% +218.40
carol_deuce 37.58 BUY Six Months to a Year 01/01/2008 $4.22 $14.33
(+0.07%)
+239.57% -10.23% +249.80
Pages: [ 1 ]  2  >>
Sponsored Links